If you're an overweight or obese adult without diabetes, taking GLP-1 drugs like those used for weight loss might lower your chances of needing heart artery procedures by about 22%.

65

Pro

0

Against

Evidence from Studies

Supporting (1)

65

Community contributions welcome

65

Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis

Systematic Review With Meta-Analysis

Human

2024

The study looked at whether GLP-1 drugs reduce heart problems in overweight people without diabetes, and found they do. The result matches the claim that these drugs lower the need for heart procedures.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis

Score: 65

DOI: 10.3389/fcvm.2024.1453297

Similar Assertions

If you're an overweight or obese adult without diabetes, taking GLP-1 drugs like Ozempic might lower your chances of having a heart attack by about 27% compared to taking a fake pill.

65

0

89%

Taking GLP-1 drugs like Ozempic doesn’t seem to lower the chance of having a stroke for people who are overweight or obese but don’t have diabetes, at least compared to taking a dummy pill.

0

65

86%

If you're overweight or obese but don't have diabetes, taking GLP-1 drugs like Ozempic can lower your chances of having heart problems by about 1 in 4 compared to not taking them.

65

0

85%

Losing just 1 kilogram (about 2.2 pounds) of body weight while taking GLP-1 diabetes drugs is linked to a 7% lower chance of having a heart attack, stroke, or dying from heart disease.

48

0

81%

For people with type 2 diabetes, GLP-1 drugs like semaglutide and dulaglutide lower the chance of having a stroke caused by a blood clot by nearly 1 in 6 — more than any other diabetes medicine.

1

0

80%